ATE384801T1 - Verfahren zur wirtsanpassung von retroviralen vektoren - Google Patents

Verfahren zur wirtsanpassung von retroviralen vektoren

Info

Publication number: ATE384801T1
Authority: AT; Austria
Prior art keywords: retrovirus; retroviral vector; retroviral; selected characteristics; retroviral vectors
Prior art date: 1995-12-15

Application number

AT96942463T

Other languages

English (en)

Inventor

Alan Kingsman

Susan Kingsman

Paula Cannon

Martin Nowak

Original Assignee

Oxford Biomedica Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-12-15

Filing date

1996-12-16

Publication date

2008-02-15

1996-12-16 Application filed by Oxford Biomedica Ltd filed Critical Oxford Biomedica Ltd

2008-02-15 Application granted granted Critical

2008-02-15 Publication of ATE384801T1 publication Critical patent/ATE384801T1/de

Links

239000013598 vector Substances 0.000 title abstract 8
230000001177 retroviral effect Effects 0.000 title abstract 7
238000000034 method Methods 0.000 title abstract 2
230000006978 adaptation Effects 0.000 title 1
241001430294 unidentified retrovirus Species 0.000 abstract 4
238000004519 manufacturing process Methods 0.000 abstract 2
238000001415 gene therapy Methods 0.000 abstract 1
238000000338 in vitro Methods 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
- C12N2740/13041—Use of virus, viral particle or viral elements as a vector
- C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Biophysics (AREA)
Microbiology (AREA)
Plant Pathology (AREA)
Molecular Biology (AREA)
Physics & Mathematics (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Virology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Traffic Control Systems (AREA)
Developing Agents For Electrophotography (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Collating Specific Patterns (AREA)

AT96942463T 1995-12-15 1996-12-16 Verfahren zur wirtsanpassung von retroviralen vektoren ATE384801T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9525639.2A GB9525639D0 (en)	1995-12-15	1995-12-15	Improved retroviral vectors

Publications (1)

Publication Number	Publication Date
ATE384801T1 true ATE384801T1 (de)	2008-02-15

Family

ID=10785464

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT96942463T ATE384801T1 (de)	1995-12-15	1996-12-16	Verfahren zur wirtsanpassung von retroviralen vektoren

Country Status (12)

Country	Link
US (1)	US6168916B1 (de)
EP (1)	EP0870048B1 (de)
JP (1)	JP2000501286A (de)
KR (1)	KR20000064409A (de)
AT (1)	ATE384801T1 (de)
AU (1)	AU719271B2 (de)
CA (1)	CA2239783A1 (de)
DE (1)	DE69637414T2 (de)
GB (1)	GB9525639D0 (de)
IL (1)	IL124541A0 (de)
NZ (1)	NZ330536A (de)
WO (1)	WO1997022709A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2304983A1 (en) *	1997-09-24	1999-04-01	The Regents Of The University Of California	Non-primate lentiviral vectors and packaging systems
GB9803351D0 (en)	1998-02-17	1998-04-15	Oxford Biomedica Ltd	Anti-viral vectors
US6958226B1 (en)	1998-09-11	2005-10-25	The Children's Medical Center Corp.	Packaging cells comprising codon-optimized gagpol sequences and lacking lentiviral accessory proteins
US6365410B1 (en) *	1999-05-19	2002-04-02	Genencor International, Inc.	Directed evolution of microorganisms
US6762031B2 (en)	2000-06-16	2004-07-13	University Of Medicine And Dentistry Of New Jersey	Targeting viral vectors to specific cells
AU2001292711A1 (en) *	2000-09-18	2002-03-26	Genetic Therapy, Inc.	Stress resistant retroviruses
US7575924B2 (en)	2000-11-13	2009-08-18	Research Development Foundation	Methods and compositions relating to improved lentiviral vectors and their applications
DE60232785D1 (de)	2001-03-14	2009-08-13	Myriad Genetics Inc	Tsg101-gag-wechselwirkung und ihre verwendung
US6613534B2 (en)	2001-03-20	2003-09-02	Wake Forest University Health Sciences	MAP-2 as a determinant of metastatic potential
WO2003012054A2 (en)	2001-08-02	2003-02-13	Institut Clayton De La Recherche	Methods and compositions relating to improved lentiviral vector production systems
CN1606456A (zh) *	2001-10-02	2005-04-13	克雷顿研究院	限制性表达慢病毒载体
AU2003258658A1 (en) *	2002-08-29	2004-03-19	Andreas Beck	Improved dna and proteins
CN1759182A (zh) *	2002-11-22	2006-04-12	克雷顿研究院	调节基因的组合物和系统
JP2009522281A (ja)	2005-12-28	2009-06-11	トランスレーショナルセラピューティクス，インク．	翻訳機能障害に基づく治療法
AU2007260817A1 (en)	2006-06-23	2007-12-27	Myriad Genetics, Inc.	DPYD gene variants and use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4211843A (en)	1977-11-30	1980-07-08	L'institut Armand-Frappier	Strain of measles virus and process of producing the same
AT392480B (de)	1988-12-13	1991-04-10	Koelbl Oskar	Lebendvakzine gegen die svc (fruehjahrsviraemie der karpfen) und ihre herstellung
JPH09507741A (ja)	1992-06-10	1997-08-12	アメリカ合衆国	ヒト血清による不活性化に耐性のあるベクター粒子
ATE263252T1 (de) *	1992-11-09	2004-04-15	Us Health	Erzielbare vektorenpartikel
WO1994027643A1 (en) *	1993-06-01	1994-12-08	Targeted Genetics Corporation	Envelope fusion vectors for use in gene delivery
US5906928A (en)	1993-07-30	1999-05-25	University Of Medicine And Dentistry Of New Jersey	Efficient gene transfer into primary murine lymphocytes obviating the need for drug selection

1995
- 1995-12-15 GB GBGB9525639.2A patent/GB9525639D0/en active Pending
1996
- 1996-12-16 WO PCT/GB1996/003104 patent/WO1997022709A1/en not_active Ceased
- 1996-12-16 US US09/091,305 patent/US6168916B1/en not_active Expired - Fee Related
- 1996-12-16 NZ NZ330536A patent/NZ330536A/xx not_active IP Right Cessation
- 1996-12-16 IL IL12454196A patent/IL124541A0/xx unknown
- 1996-12-16 AT AT96942463T patent/ATE384801T1/de not_active IP Right Cessation
- 1996-12-16 JP JP9519976A patent/JP2000501286A/ja not_active Ceased
- 1996-12-16 CA CA002239783A patent/CA2239783A1/en not_active Abandoned
- 1996-12-16 DE DE69637414T patent/DE69637414T2/de not_active Expired - Fee Related
- 1996-12-16 EP EP96942463A patent/EP0870048B1/de not_active Expired - Lifetime
- 1996-12-16 AU AU28628/97A patent/AU719271B2/en not_active Ceased
- 1996-12-16 KR KR1019980704498A patent/KR20000064409A/ko not_active Ceased

Also Published As

Publication number	Publication date
WO1997022709A1 (en)	1997-06-26
CA2239783A1 (en)	1997-06-26
AU719271B2 (en)	2000-05-04
NZ330536A (en)	1999-11-29
EP0870048A1 (de)	1998-10-14
DE69637414T2 (de)	2009-01-22
EP0870048B1 (de)	2008-01-23
DE69637414D1 (de)	2008-03-13
AU2862897A (en)	1997-07-14
KR20000064409A (ko)	2000-11-06
GB9525639D0 (en)	1996-02-14
JP2000501286A (ja)	2000-02-08
IL124541A0 (en)	1998-12-06
US6168916B1 (en)	2001-01-02

Similar Documents

Publication	Publication Date	Title
DE69637414D1 (de)	2008-03-13	Verfahren zur wirtsanpassung von retroviralen vektoren
ATE152748T1 (de)	1997-05-15	Verfahren zur herstellung von siloxanoxyalkylencopolymeren
DE68924174D1 (de)	1995-10-12	Verfahren zur rekombination in vivo von teilweise homologen dns-sequenzen.
DE3583361D1 (de)	1991-08-08	Verfahren zur herstellung von thrombin-inhibitoren.
GB9827152D0 (en)	1999-02-03	Characterisation of gene function using double stranded rna inhibition
DE69838294D1 (de)	2007-10-04	Verfahren zur Herstellung von Nukleinsäurekonstrukten
EP0767562A3 (de)	2000-05-24	Verfahren und Vorrichtung zur Kommunikationssteuerung
DE69738737D1 (de)	2008-07-10	Verfahren zur herstellung von retroviralen vektoren für die gentherapie
ATE309353T1 (de)	2005-11-15	Verfahren zur herstellung von rekombinanten peptiden
DE69839879D1 (de)	2008-09-25	Methode zur erhöhung der fruchtgrösse einer pflanze
DE3853145D1 (de)	1995-03-30	Verfahren zur Herstellung von xbaI-Restriktionsendonuklease und -methylase.
DE69931493D1 (de)	2006-06-29	Verfahren zur herstellung von hydroxymethylthiobuttersäure
DE69031803D1 (de)	1998-01-22	Verfahren und nukleinsäuresequenzen zur expression des zellulose-synthase-operons
EE03074B1 (et)	1998-02-16	Rekombinantsed eukarüootsed rakud, nende saamiseks vajalikud DNA järjestused, meetod eukarüootsete rakkude konstrueerimiseks ja sekreteeritavate valkude ning biomassi tootmismeetod
CA2197075A1 (en)	1996-02-22	Method of Gene Therapy Using DNA Vectors Without Selection Marker Gene
DE3863378D1 (de)	1991-08-01	Verfahren zur herstellung von koks hoher qualitaet.
DE3888648D1 (de)	1994-04-28	Verfahren zur Herstellung von HgiAI-Restriktionsendonuklease und -methylase.
ATE106448T1 (de)	1994-06-15	Verfahren zur herstellung von hinpi- restriktionsendonuklease und -methylase.
DE68910087D1 (de)	1993-11-25	Verfahren zur Herstellung von harten, ein Enzym enthaltenden Kandis.
ATE239695T1 (de)	2003-05-15	Stereoselektive verfahren zur herstellung von gabapentinanalogen
ATE112318T1 (de)	1994-10-15	Protease, reverse transcriptase und endonuklease von retroviren und verfahren zur herstellung dieser enzyme.
ATE235461T1 (de)	2003-04-15	Verfahren zur herstellung von 3-cyano-2,4- dihalogen-5-fluor-benzoesäuren
ATE251615T1 (de)	2003-10-15	Verfahren zur herstellung von substituierten triazolinonen
DE69010433D1 (de)	1994-08-11	Verfahren zur Herstellung von Magnetronanoden.
DE50001638D1 (de)	2003-05-08	Verfahren zur herstellung von 4,6-dichlorpyrimidin

Legal Events

Date	Code	Title	Description
2008-07-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties